KEEP Intervention for People Newly Diagnosed With Parkinson's (KEEP)
1 novembre 2022 mis à jour par: Ledia Alushi, University of Cambridge
KEEP- A Randomised Feasibility Study of a Co-designed Physical Health Education Intervention to Improve Knowledge, Exercise Efficacy and Participation for Newly Diagnosed People With Parkinson's.
Parkinson's Disease (PD) is a progressive neurological condition that affects movement, balance and cognition, resulting in loss of independence and compromised quality of life over the course of the condition. Research suggests that those detrimental outcomes can be reduced through physical activity (PA) and exercise, especially when those are started early. Educating people with Parkinson's (PwP) on the role of PA and exercise in PD progression can boost PA engagement by increasing enablers such as exercise self-efficacy and removing barriers such as misinformation about exercise and exercise outcomes.
Working closely with PwP and healthcare professionals, a physical health education programme was co-designed to address the needs and preferences of PwP around exercise and PA education. The process was supervised by the patient and Public Involvement group attended by PwP, academics, researchers and clinicians working with PwP.
The study will utilise an assessor blinded randomised controlled design to investigate the acceptability and feasibility of delivering an online physical health education programme for PwP who are newly diagnosed. Thirty PwP, diagnosed in the last 12-months, will be randomly allocated into two groups: 1) the intervention group in which participants will receive online education modules and will be invited to attend virtual group sessions with a specialist neuro-physiotherapist; 2) the control group which will follow the usual care pathway and participants will receive Parkinson's UK booklets.
The aim of the study is to explore an alternative approach to standard care regarding patient education in PD and evaluate the feasibility and acceptability of a co-designed education intervention for newly diagnosed PwP delivered online. Feasibility data will be collected during the study and acceptability data will be assessed via a questionnaire at the end. Outcomes including PA levels, exercise knowledge, exercise efficacy, and participation will be assessed at baseline, post-intervention and at 6 months.
Aperçu de l'étude
Statut
Actif, ne recrute pas
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Réel)
30
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Cambridge, Royaume-Uni, CB2 0SZ
- Department of Psychiatry
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans et plus (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Clinical diagnosis of Idiopathic Parkinson's Disease
- Within 12 months since diagnosis
- Stable medication regime for four weeks prior to initiation of trial
- Ability to understand written English
Exclusion Criteria:
- Acute illness
- History of neurological disorder other than Parkinson Disease
- Diagnosis of dementia or significant cognitive impairments
- Participation in NHS structured PD-specific education program with or without exercise classes in the last year
- Unable to understand written English
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Intervention group
The experimental group will receive: Online education modules Online group discussions facilitated by Specialist Physiotherapist |
Educational intervention
|
|
Comparateur actif: Control Group
The comparator for this study is usual care pathway.
Under the usual care pathway, participants will receive education booklets on exercise by Parkinson's UK.
|
booklet from Parkinson's UK
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Acceptability assessment 1: Recruitment rate
Délai: Through study completion (12 months)
|
Assessment of recruitment rate of study (% of eligible participants enrolled)
|
Through study completion (12 months)
|
|
Acceptability assessment 2: Education programme compliance
Délai: Through study completion (12 months)
|
Compliance with the online education programme (% of sessions completed)
|
Through study completion (12 months)
|
|
Acceptability assessment 3: Drop out rate
Délai: Through study completion (12 months)
|
Comparison of drop out rates (%) between the intervention group and control group
|
Through study completion (12 months)
|
|
Acceptability assessment 4: Acceptability of Intervention
Délai: Completed at the end of participation in the study (after 8 weeks)
|
A questionnaire designed to assess satisfaction with the education intervention.
it includes multiple choice and open ended questions.
|
Completed at the end of participation in the study (after 8 weeks)
|
|
Feasibility of delivering the intervention online
Délai: Through study completion (12 months)
|
Assessment of any technical problems or difficulties accessing online intervention as reported by participants
|
Through study completion (12 months)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Unified Parkinson's Disease Rating Scale Part 3
Délai: Baseline(week 0) and follow up (6-month post intervention)
|
The UPDRS is the gold-standard scale for Parkinson's assessment and has four parts.
For this study only UPDRS III, motor examination will be completed by a trained assessor.
UPDRS III total scores range from 7 to 86 points, with higher scores indicating more severe impairment..
|
Baseline(week 0) and follow up (6-month post intervention)
|
|
MiniBESTest
Délai: Baseline(week 0) and follow up (6-month post intervention)
|
The Mini-BEST is a 14-item scale that assesses dynamic balance components including anticipatory postural adjustments, reactive postural control, sensory orientation and dynamic gait.
The data is based on a total score of 28 points, with higher score indicating better task performance.
|
Baseline(week 0) and follow up (6-month post intervention)
|
|
Five time Sit To Stand
Délai: Baseline(week 0) and follow up (6-month post intervention)
|
Five time sit to stand is a validated test used to assess functional lower extremity strength, balance and risk falls in older adults.
It has been used in PD population with high interrater and test-retest reliability.
Longer time to complete indicates worse task performance.
|
Baseline(week 0) and follow up (6-month post intervention)
|
|
Self-efficacy for Exercise
Délai: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
The Self-Efficacy for exercise (SEE) scale is a 9-item validated scale which assesses a person self-efficacy to exercise under different circumstances.
This scale is a modified version of Bandura's Exercise Self-Efficacy Scale and ask participants to rate their perceived exercise efficacy on a scale form 0 meaning not confident at all to 10 meaning very confident.
Higher score indicate higher self-efficacy
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Hospital Anxiety and Depression Scale
Délai: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Hospital Anxiety and Depression Scale (HADS) is a widely used questionnaire to measure anxiety and depression.
A self-reported brief instrument which includes 14 questions aiming to detect and indicate severity of anxiety and depression.
It has been used before and is a validated and reliable tool to use in Parkinson's population.
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Apathy Evaluation Scale
Délai: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Apathy Evaluation Scale (AES) is a standardised and validated self-rating instrument to evaluate apathy.
It consists of 18 items that are scored on a 4-point Likert Scale, with highest score indicating more severe apathy
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Multidimensional Outcome Expectation Scale
Délai: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Outcome expectations about the benefits of regular exercise and PA will be measured by the Multidimensional Outcomes Expectations for Exercise Scale (MOEES).
The MOEES has 15 items that reflect three subdomains of outcome expectations.
The items were rated on a five-point scale from 1 (Strongly disagree) to 5 (Strongly agree) and summed to form the subscale measures of outcome expectations with higher scores reflecting greater beliefs about the benefits of regular exercise and physical activity.
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Oxford Participation and Activities Questionnaire
Délai: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Oxford Participation and Activities Questionnaire (Ox-PAQ) is a patient-reported outcome measure comprised of 23 items aiming to assess participation and activity in patients with long-term conditions.
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Recent Physical Activity Questionnaire
Délai: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Physical Activity will be measured subjectively and objectively.
Subjectively it will be measured via the self-reported Recent Physical Activity Questionnaire (RPAQ), which is designed to assess PA in everyday life in the last 4 weeks.
The questionnaire has three sections assessing a range of activities in different domains (around the house, work and recreation).
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Knowledge of Exercise and Physical Activity
Délai: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Knowledge of Exercise and Physical Activity questionnaire is a 10-item knowledge questionnaire around the role of exercise and physical activity in the management of PD and it has been designed by the PI to assess knowledge levels.
A total score of 10 indicates better knowledge scores.
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Wrist-worn accelerometer
Délai: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Objectively, physical activity will be measured with the use of a wrist-worn accelerometer (GeneActiv monitor) over 7 consecutive days.
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
18 juin 2022
Achèvement primaire (Réel)
21 septembre 2022
Achèvement de l'étude (Anticipé)
18 juin 2023
Dates d'inscription aux études
Première soumission
2 février 2022
Première soumission répondant aux critères de contrôle qualité
11 février 2022
Première publication (Réel)
23 février 2022
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
4 novembre 2022
Dernière mise à jour soumise répondant aux critères de contrôle qualité
1 novembre 2022
Dernière vérification
1 novembre 2022
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- A096150
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
INDÉCIS
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .